Cita APA

Derosa, G., & Maffioli, P. (2018). Ertugliflozin: A sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetes. Ther Clin Risk Manag.

Chicago Style Citation

Derosa, Giuseppe, i Pamela Maffioli. "Ertugliflozin: A Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor for Glycemic Control in Type 2 Diabetes." Ther Clin Risk Manag 2018.

Cita MLA

Derosa, Giuseppe, i Pamela Maffioli. "Ertugliflozin: A Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor for Glycemic Control in Type 2 Diabetes." Ther Clin Risk Manag 2018.